Imke A M Ditters

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 2

Top Topics

Prognostic Factors

Ejection Fraction

Replacement Therapy

Top Venues

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Imke A M Ditters, Harmke A van Kooten, Nadine A M E van der Beek, Jacqueline F Hardon, Gamida Ismailova, Esther Brusse, Michelle E Kruijshaar, Ans T van der Ploeg, Johanna M P van den Hout, Hidde H Huidekoper
Home-Based Infusion of Alglucosidase Alfa Can Safely be Implemented in Adults with Late-Onset Pompe Disease: Lessons Learned from 18,380 Infusions. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy (2023)
Imke A M Ditters, Harmke A van Kooten, Nadine A M E van der Beek, Ans T van der Ploeg, Hidde H Huidekoper, Johanna M P van den Hout
Are Anti-rhGAA Antibodies a Determinant of Treatment Outcome in Adults with Late-Onset Pompe Disease? A Systematic Review. Biomolecules 13 (9) (2023)